Supplemental material
Drug Delivery
Volume 30, 2023 - Issue 1
Open access
2,198
Views
1
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE
SREKA-targeted liposomes for highly metastatic breast cancer therapy
Balázs Vária National Institute of Oncology, Department of Experimental Pharmacology, National Tumor Biology Laboratory, Budapest, Hungary;b School of Ph.D. Studies, Semmelweis University, Budapest, HungaryView further author information
, Levente Dókusc Research Group of Peptide Chemistry, Eötvös Loránd Research Network, Budapest, HungaryView further author information
, Adina Borbélyd Faculty of Science, Institute of Chemistry, Eötvös Loránd University, Budapest, Hungary;e MTA-ELTE Lendület Ion Mobility Mass Spectrometry Research Group, Budapest, HungaryView further author information
, Anikó Gaálf Eötvös, Loránd Research Network, Research Centre for Natural Sciences, Institute of Materials and Environmental Chemistry, Biological Nanochemistry Research Group, Budapest, HungaryView further author information
, Diána Vári-Mezőa National Institute of Oncology, Department of Experimental Pharmacology, National Tumor Biology Laboratory, Budapest, Hungary;b School of Ph.D. Studies, Semmelweis University, Budapest, HungaryView further author information
, Ivan Ranđelovića National Institute of Oncology, Department of Experimental Pharmacology, National Tumor Biology Laboratory, Budapest, HungaryView further author information
, Anna Sólyom-Tiszag Department of Tumor Biology, National Korányi Institute of Pulmonology, Budapest, HungaryView further author information
, Zoltán Vargaf Eötvös, Loránd Research Network, Research Centre for Natural Sciences, Institute of Materials and Environmental Chemistry, Biological Nanochemistry Research Group, Budapest, HungaryView further author information
, Norbert Szoboszlaid Faculty of Science, Institute of Chemistry, Eötvös Loránd University, Budapest, HungaryView further author information
, Gábor Mezőc Research Group of Peptide Chemistry, Eötvös Loránd Research Network, Budapest, Hungary;d Faculty of Science, Institute of Chemistry, Eötvös Loránd University, Budapest, HungaryCorrespondence[email protected]
View further author information
& View further author information
József Tóvária National Institute of Oncology, Department of Experimental Pharmacology, National Tumor Biology Laboratory, Budapest, Hungary;b School of Ph.D. Studies, Semmelweis University, Budapest, HungaryCorrespondence[email protected]
View further author information
show allView further author information
Article: 2174210
|
Received 21 Oct 2022, Accepted 24 Jan 2023, Published online: 08 Feb 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.